BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borghammer P. The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson's Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline. J Parkinsons Dis 2021;11:455-74. [PMID: 33682732 DOI: 10.3233/JPD-202481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Banwinkler M, Dzialas V, Hoenig MC, van Eimeren T; Parkinson's Progression Markers Initiative. Gray Matter Volume Loss in Proposed Brain-First and Body-First Parkinson's Disease Subtypes. Mov Disord 2022. [PMID: 35943058 DOI: 10.1002/mds.29172] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Klæstrup IH, Just MK, Holm KL, Alstrup AKO, Romero-ramos M, Borghammer P, Van Den Berge N. Impact of aging on animal models of Parkinson's disease. Front Aging Neurosci 2022;14:909273. [DOI: 10.3389/fnagi.2022.909273] [Reference Citation Analysis]
3 Fedorova TD, Knudsen K, Andersen KB, Horsager J, Skjærbæk C, Beier CP, Sommerauer M, Svendsen KB, Otto M, Borghammer P. Imaging progressive peripheral and central dysfunction in isolated REM sleep behaviour disorder after 3 years of follow-up. Parkinsonism Relat Disord 2022;101:99-104. [PMID: 35853349 DOI: 10.1016/j.parkreldis.2022.07.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 García-Gomar MG, Singh K, Cauzzo S, Bianciardi M. In vivo structural connectome of arousal and motor brainstem nuclei by 7 Tesla and 3 Tesla MRI. Hum Brain Mapp 2022. [PMID: 35633277 DOI: 10.1002/hbm.25962] [Reference Citation Analysis]
5 Just MK, Gram H, Theologidis V, Jensen PH, Nilsson KPR, Lindgren M, Knudsen K, Borghammer P, Van Den Berge N. Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies. Front Aging Neurosci 2022;14:907293. [DOI: 10.3389/fnagi.2022.907293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ye R, O'Callaghan C, Rua C, Hezemans FH, Holland N, Malpetti M, Jones PS, Barker RA, Williams-Gray CH, Robbins TW, Passamonti L, Rowe J. Locus Coeruleus Integrity from 7 T MRI Relates to Apathy and Cognition in Parkinsonian Disorders. Mov Disord 2022. [PMID: 35576973 DOI: 10.1002/mds.29072] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rahimpour S, Zhang SC, Vitek JL, Mitchell KT, Turner DA. Comparative efficacy of surgical approaches to disease modification in Parkinson disease. NPJ Parkinsons Dis 2022;8:33. [PMID: 35338165 DOI: 10.1038/s41531-022-00296-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Ichimata S, Yoshida K, Visanji NP, Lang AE, Nishida N, Kovacs GG, Giaccone G. Patterns of Mixed Pathologies in Down Syndrome. JAD 2022. [DOI: 10.3233/jad-215675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Murtomäki K, Mertsalmi T, Jaakkola E, Mäkinen E, Levo R, Nojonen T, Eklund M, Nuuttila S, Lindholm K, Pekkonen E, Joutsa J, Noponen T, Ihalainen T, Kaasinen V, Scheperjans F. Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease. Mov Disord 2022. [PMID: 35274368 DOI: 10.1002/mds.28986] [Reference Citation Analysis]
10 Henderson MX, Henrich MT, Geibl FF, Oertel WH, Brundin P, Surmeier DJ. The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Van Den Berge N, Ulusoy A. Animal models of brain-first and body-first Parkinson's disease. Neurobiology of Disease 2022;163:105599. [DOI: 10.1016/j.nbd.2021.105599] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
12 Folke J, Ferreira N, Brudek T, Borghammer P, Van Den Berge NVD. Passive Immunization in Alpha-Synuclein Preclinical Animal Models. Biomolecules 2022;12:168. [DOI: 10.3390/biom12020168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
13 Horsager J, Knudsen K, Sommerauer M. Clinical and imaging evidence of brain-first and body-first Parkinson's disease. Neurobiol Dis 2022;:105626. [PMID: 35031485 DOI: 10.1016/j.nbd.2022.105626] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
14 Chen H, Wang K, Scheperjans F, Killinger B. Environmental triggers of Parkinson's disease - Implications of the Braak and dual-hit hypotheses. Neurobiol Dis 2021;163:105601. [PMID: 34954321 DOI: 10.1016/j.nbd.2021.105601] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Dong WL, Zhong JH, Chen YQ, Xie JF, Qin YY, Xu JP, Cai NB, Li MF, Liu L, Wang HT. Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson's disease models. Acta Pharmacol Sin 2021;42:1991-2003. [PMID: 34531546 DOI: 10.1038/s41401-021-00768-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nazmuddin M, van Dalen JW, Borra RJH, Stormezand GN, van der Horn HJ, van der Zee S, Boertien J, van Laar T. Postural and gait symptoms in de novo Parkinson's disease patients correlate with cholinergic white matter pathology. Parkinsonism Relat Disord 2021;93:43-9. [PMID: 34784526 DOI: 10.1016/j.parkreldis.2021.11.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Fan TS, Liu SC, Wu RM. Alpha-Synuclein and Cognitive Decline in Parkinson Disease. Life (Basel) 2021;11:1239. [PMID: 34833115 DOI: 10.3390/life11111239] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
18 Borghammer P, Horsager J, Andersen K, Van Den Berge N, Raunio A, Murayama S, Parkkinen L, Myllykangas L. Neuropathological evidence of body-first vs. brain-first Lewy body disease. Neurobiol Dis 2021;161:105557. [PMID: 34763110 DOI: 10.1016/j.nbd.2021.105557] [Reference Citation Analysis]
19 Yoo SW, Kim JS, Oh YS, Ryu DW, Ha S, Yoo JY, Lee KS. Cardiac sympathetic burden reflects Parkinson disease burden, regardless of high or low orthostatic blood pressure changes. NPJ Parkinsons Dis 2021;7:71. [PMID: 34385459 DOI: 10.1038/s41531-021-00217-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]